Income Taxes - Additional Information (Detail) (USD $)
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
Income Tax Disclosure [Line Items] | |||
Deferred Tax Assets, Valuation Allowance | $ 50,567,000us-gaap_DeferredTaxAssetsValuationAllowance | $ 41,142,000us-gaap_DeferredTaxAssetsValuationAllowance | |
Effective Income Tax Rate Reconciliation Prior Year State Net Operating Loss True Up | 1.00%cndo_EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp | 5.00%cndo_EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp | |
Effective Income Tax Rate Reconciliation Prior Year Federal Net Operating Loss True Up | 0.00%cndo_EffectiveIncomeTaxRateReconciliationPriorYearFederaNetOperatingLossTrueUp | ||
Tax Payer Relief Act Research Credit Extension Period | 2 years | ||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 9,400,000us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount | ||
Orphan Drug Tax Credit [Member] | |||
Income Tax Disclosure [Line Items] | |||
Tax Credit Carryforward, Amount |
2,100,000us-gaap_TaxCreditCarryforwardAmount / us-gaap_CreditFacilityAxis = cndo_OrphanDrugTaxCreditMember |
||
Research Tax Credit Carryforward [Member] | |||
Income Tax Disclosure [Line Items] | |||
Tax Credit Carryforward, Amount |
3,800,000us-gaap_TaxCreditCarryforwardAmount / us-gaap_TaxCreditCarryforwardAxis = us-gaap_ResearchMember |
||
Domestic Tax Authority [Member] | |||
Income Tax Disclosure [Line Items] | |||
Operating Loss Carryforwards |
104,000,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_DomesticCountryMember |
||
Domestic Tax Authority [Member] | Additional Paid-in Capital [Member] | |||
Income Tax Disclosure [Line Items] | |||
Operating Loss Carryforwards |
1,800,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_DomesticCountryMember / us-gaap_StatementEquityComponentsAxis = us-gaap_AdditionalPaidInCapitalMember |
||
State and Local Jurisdiction [Member] | |||
Income Tax Disclosure [Line Items] | |||
Operating Loss Carryforwards |
50,700,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_StateAndLocalJurisdictionMember |
||
State and Local Jurisdiction [Member] | Additional Paid-in Capital [Member] | |||
Income Tax Disclosure [Line Items] | |||
Operating Loss Carryforwards |
$ 1,600,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_StateAndLocalJurisdictionMember / us-gaap_StatementEquityComponentsAxis = us-gaap_AdditionalPaidInCapitalMember |
X | ||||||||||
- Definition
Effective Income Tax Rate Reconciliation Prior Year Federal Net Operating Loss True Up No definition available.
|
X | ||||||||||
- Definition
Effective income tax rate reconciliation prior year state net operating loss true up. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Tax payer relief act research credit extension period. No definition available.
|
X | ||||||||||
- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|